Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19
TO: